Orphazyme provides regulatory update following Type A meeting with FDA on arimoclomol in Niemann-Pick disease type C

Written by Customer Service on October 31, 2021. Posted in Public Companies.

Orphazyme A/SCompany announcement No. 24/2021Inside informationCompany Registration No. 32266355 Progress made in understanding potential resolution of topics outlined in Complete Response Letter, including need for additional data to support NDA FDA recommends the company provides supplemental information and analyses, and the FDA offers to have further interactions to identify a path to resubmission for arimoclomol in NPC Copenhagen – October 31, 2021 – Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical company, today provides an update on the regulatory status in the United States of its investigational product arimoclomol for Niemann-Pick disease type C (NPC) following a recently held Type A meeting with the U.S. Food and Drug Administration (FDA). The Company had a collaborative dialogue with the FDA during...

Alm. Brand A/S completes capital reduction by changing share denomination

Written by Customer Service on October 31, 2021. Posted in Public Companies.

Announcement no. 31/2021 Alm. Brand A/S completes capital reduction by changing share denomination At the extraordinary general meeting of Alm. Brand A/S held on 2 September 2021, the shareholders resolved to reduce the company’s share capital by nominally DKK 1,387,026,000 from nominally DKK 1,541,140,000 to nominally DKK 154,114,000 at par value for allocation to distributable reserves under equity. As the company has not received any claims during the statutory claims filing period, the capital reduction has now been finally registered in the computer systems of the Danish Business Authority. The capital reduction was completed by changing the denomination of the company’s shares from DKK 10 per share to DKK 1 per share. The capital reduction does not change the number of shares. With reference to section 32 of the Capital Markets...

Skeljungur hf.: Conditions removed regarding financing and due diligence relating to the sale of P/F Magn to Sp/f Orkufelagið. Skeljungur plans to invest up to 23% of the total selling price of P/F Magn in Sp/f Orkufelagið.

Written by Customer Service on October 31, 2021. Posted in Public Companies.

It was announced last 2 September that Skeljungur had made a decision to enter into exclusive negotiations with Sp/f Orkufelagið on the sale of all the shares in Skeljungur’s subsidiary in the Faroe Islands, P/F Magn, based on an offer to buy made by Sp/f Orkufelagið. Sp/f Orkufelagið has now declared to Skeljungur that reservations regarding financing and due diligence have either been satisfied or waived. The selling price of P/F Magn remains unchanged from the amount announced earlier, i.e. 615 million DKK, or 12.3 billion ISK. Skeljungur has decided to participate in the funding of Sp/f Orkufelagið by re-investing up to 23% of the total proceeds from the transaction in Sp/f Orkufelagið and consequently Skeljungur will own up to 49% stake in Sp/Orkufelagið. Accordingly, the estimated impact of the transaction on Skeljungur’s financial...

UPP Olaines OÜ consolidated unaudited financial results for Q3 and 9 months of 2021

Written by Customer Service on October 31, 2021. Posted in Public Companies.

MANAGEMENT REPORT FOR 9 MONTHS 2021 General information UPP Olaines OÜ (hereafter ‘the Company’ and ‘the Group’ when referred together with subsidiaries) was established for the purpose of funding, acquiring and managing the real estate investment of Olaines Logistics Park: (buildings and land) located at “Šarlotes”, Olaines county, Olaines parish, Latvia, cadastre number 8080 003 0029, registered in the Land Register compartment No.5439 of the city of Olaine parish. The Company was established on 24.08.2017 and had no economic activity until 15.12.2017, when it acquired the cold storage warehouse Olaines Logistics Park. The management board is aware of no trends, uncertainties, demands, commitments or events that are reasonably likely to have a material effect on the Company’s prospects for the period after the reporting period of these...

ESA signs contract with Danish Aerospace Company A/S for an extra E4D

Written by Customer Service on October 31, 2021. Posted in Public Companies.

COMPANY ANNOUNCEMENT Odense, October 31st, 2021 Company Announcement no. 31 – 31-10-2021 ESA signs contract with Danish Aerospace Company A/S for an extra E4D Danish Aerospace Company A/S (DAC) has now signed the contract with ESA for an additional E4D model and more spares. This happened after formally being requested to make an offer for yet another flight model of the company’s future E4D-multifunction exercise equipment back in June of this year. (DAC Company Announcement no. 27). This contract now ensures ESA and NASA will have a full spare flight model available on ground when the equipment will be launched and become part of the standard complement of exercise equipment for the astronauts on the International Space Station ISS. DAC is now contracted to develop two flight- and three ground models of the new multifunction/crosstrainer...

Day: October 31, 2021